Results 51 to 60 of about 101,810 (380)
Study of firm-level strategic alliances drivers; case study Pharmaceutical industry [PDF]
پژوهشهای مدیریت عمومی, 2015 Commercialization is one of the essential element for development in The biotechnology industry. Nowadays Successful Commercialization is critical for surviving in the competitive markets.
doaj +1 more source
DEVELOPMENT PROSPECTS OF BIOPHARMACEUTICAL PLANTS IN PALEMBANG CITY
Biovalentia: Biological Research Journal, 2021 Biopharmaceutical plants or medicinal plants are plants grown in the garden that have medicinal properties. The types of biopharmaceutical plants have been cultivated for more than 5 years and are managed by the people of Palembang City who are members ...
Meri Ariyantini +2 more
doaj +1 more source
A theoretical framework for estimation of AUCs in complete and incomplete sampling designs. [PDF]
, 2009 Nonclinical in vivo animal studies have to be completed before starting clinical studies of the pharmacokinetic behavior of a drug in humans. The drug exposure in animal studies is often measured by the area under the concentration versus time curve (AUC)
Jaki, Thomas, Wolfsegger, Martin J.
core +1 more source
A case report of telitacicept in the treatment of immunocompromised and refractory lupus nephritis
Frontiers in ImmunologyLupus nephritis (LN) is a manifestation of kidney damage in systemic lupus erythematosus and is more common in Asian populations. The standard-of-care (SOC) for LN includes antimalarials, glucocorticoids, and immunosuppressants.
Yongda Lin +3 more
doaj +1 more source
Bioengineering, 2018 Eptacog alfa (NovoSeven®) is a vitamin K-dependent recombinant Factor VIIa produced by genetic engineering from baby hamster kidney (BHK) cells as a single peptide chain of 406 residues.
Othman Montacir +7 more
doaj +1 more source
Locust bean gum: exploring its potential for biopharmaceutical applications [PDF]
, 2012 Polysaccharides have been finding, in the last decades, very interesting and useful applications in the biomedical and, specifically, in the biopharmaceutical field.
Dionísio, Marita, Grenha, Ana
core +2 more sources
Determinants of biopharmaceutical R&D expenditures in China: the impact of spatiotemporal context
Scientometrics, 2021 The spatiotemporal context affects corporate behavior because any corporate activity is carried out in a specific time and space. Based on an examination on the research and development (R&D) expenditures of 284 listed biopharmaceutical companies in ...
Jiafeng Gu
semanticscholar +1 more source
Molecular Oncology, EarlyView.The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
Molecules, 2020 Adoptive cell therapy is an emerging anti-cancer modality, whereby the patient’s own immune cells are engineered to express T-cell receptor (TCR) or chimeric antigen receptor (CAR).
Camille Lombard-Banek, John E. Schiel
doaj +1 more source
Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s) [PDF]
International Journal of Health Policy and Management, 2015 Background: This article sets up the initial discussion of the evolution of biopharmaceutical innovation in China through the perspective of sectoral innovation system (SIS).
Hao Hu, Chao-Chen Chung
doaj +1 more source